comparemela.com
Home
Live Updates
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q2 2023 Earnings Call Transcript : comparemela.com
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone. And welcome to the Deciphera Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. Today’s call is being recorded.
Related Keywords
Spain
,
Italy
,
United Kingdom
,
Singapore
,
China
,
France
,
Germany
,
Canada
,
Canadian
,
Peter Lawson
,
Tucker Kelly
,
Reni Benjamin
,
Brad Canino
,
Jen Larson
,
Matt Sherman
,
Chris Raymond
,
Dan Martin
,
Michael Schmidt
,
Dan Flynn
,
Eun Yang
,
Tyler Van Buren
,
Steve Hoerter
,
Piper Sandler
,
Margarida Duarte
,
Andrew Berens
,
Research Engine
,
Incyte Corporation
,
Nasdaq
,
Zai Lab
,
Barclays
,
Pfizer
,
Head Of International
,
Deciphera Pharmaceuticals Second Quarter
,
Canadian Pharmaceutical Alliance
,
Deciphera Pharmaceuticals Inc
,
Deciphera Pharmaceuticals
,
Call Transcript August
,
Results Conference
,
Senior Vice President
,
Chief Executive Officer
,
Chief Commercial Officer
,
Chief Medical Officer
,
Chief Financial
,
Safe Harbor
,
Private Securities Litigation Reform Act
,
Supplemental New Drug Application
,
American Association
,
Cancer Research Annual Meeting
,
Kinase Switch Control Research Engine
,
Chief Scientific Officer
,
Switch Control Kinase Inhibition
,
Dash Dhanak
,
Executive Vice President
,
Chief Scientific
,
Chief Financial Officer
,
Inflation Reduction
,
Official Gazette
,
Van Buren
,
Zai Labs
,
comparemela.com © 2020. All Rights Reserved.